Eureka projects

Bioactive alginates (low guluronate) to be produced in-vivo in bacteria, and by in-vitro epimerisation of high mannuronate alginates from seaweed or bacteria. They will be used for wound healing, health supportive fish feed, fish vaccines and also combined with biopolymers for enhanced performance.
Project ID: 

We will explore a novel type of cavvine against food allergy by designing a vaccine with an antibody-like structure using recombinant allergen and a targeting unit. Canditate molecules will be tested in-vitro and in an animal model.
Project ID: 

Aim of this project is to establish a numerical framework that can be used to understand the behaviour of human or animal tissue subjected to ballistic impacts from projectiles.
Project ID: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.